APA (7th ed.) Citation

Lyu, P., Ge, L., Ma, R., Wei, R., McCrudden, C. M., Chen, T., . . . Kwok, H. F. (2018). Identification and pharmaceutical evaluation of novel frog skin-derived serine proteinase inhibitor peptide–PE-BBI (Pelophylax esculentus Bowman-Birk inhibitor) for the potential treatment of cancer. Nature Portfolio.

Chicago Style (17th ed.) Citation

Lyu, Peng, Lilin Ge, Rui Ma, Ran Wei, Cian M. McCrudden, Tianbao Chen, Chris Shaw, and Hang Fai Kwok. Identification and Pharmaceutical Evaluation of Novel Frog Skin-derived Serine Proteinase Inhibitor Peptide–PE-BBI (Pelophylax Esculentus Bowman-Birk Inhibitor) for the Potential Treatment of Cancer. Nature Portfolio, 2018.

MLA (8th ed.) Citation

Lyu, Peng, et al. Identification and Pharmaceutical Evaluation of Novel Frog Skin-derived Serine Proteinase Inhibitor Peptide–PE-BBI (Pelophylax Esculentus Bowman-Birk Inhibitor) for the Potential Treatment of Cancer. Nature Portfolio, 2018.